Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK meningitis jab bags approval by FDA
03:56am, Monday, 17'th Feb 2025
GSK PLC has bagged approval for its Penmenvy meningitis vaccine by the US Food and Drug Administration. Designed to target five major serogroups of meningitis-causing Neisseria meningitidis bacteria,
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSK
09:30pm, Sunday, 16'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK
07:15pm, Sunday, 16'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of GSK plc (NYSE: GSK) between Febru
GSK plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
04:22pm, Sunday, 16'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK , Feb. 16, 2025 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed ag
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSK
11:45am, Sunday, 16'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
GSK plc Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
11:00am, Sunday, 16'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the C
GSK plc Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - GSK
08:00am, Sunday, 16'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK CITY, NY / ACCESS Newswire / February 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GS
Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)
09:27pm, Saturday, 15'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
Levi & Korsinsky Notifies Shareholders of GSK plc(GSK) of a Class Action Lawsuit and an Upcoming Deadline
06:01pm, Saturday, 15'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK, NY / ACCESS Newswire / February 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against GSK plc
11:00am, Saturday, 15'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the C
NEW YORK, NY / ACCESS Newswire / February 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc ("GSK" or the "Company") (NYSE:GSK). Such investors are advised
